The new molecule arrives in Argentina to combat skin hyperpigmentation problems

The new molecule arrives in Argentina to combat skin hyperpigmentation problems
The new molecule arrives in Argentina to combat skin hyperpigmentation problems

Brand Studio for La Roche-Posay

The pigmentary disorders represent one of the Most frequent consultations in dermatology. Skin spots are a cause of concern for half of the world’s population and that is why it is a topic that is constantly researched. After 18 years of research, during which more than 100,000 molecules were examined, the mThe biggest revolution in the field of pigmentation: Melasyl.

Skin spots are a cause of concern for half of the world’s population: today a serum offers the best solution

This is one innovative moleculemulti-patented by L’Oréal Groupe, which is present in the new Serum Mela B3 from La Roche-Posay: improves 85% of persistent dark spots after 8 weeks. This product is a true revolution in the treatment of stains, since it is more effective and offers better results than anything known until now. The serum addresses the main triggers of pigmentation, effectively combats hyperpigmentation and prevents the reappearance of spots.

He Mela B3 serum It is a non-comedogenic product, tested even on sensitive skin and can be used every day. It also has a new dropper that allows for a much cleaner application.

While Melasyl is the revolutionary new molecule, Mela B3 contains other beneficial components like 10% of niacinamide, hyaluronic acid and LHC, that act as antioxidants, anti-inflammatories and promoters of cell renewal for more radiant and uniform skin.

Melasyl is the name of the innovative molecule patented by La Roche-Posay

This product comes to improve the version of the Pure Niacinamide 10 serum, thanks to its revolutionary formula that combats hyperpigmentation like never before. In the investigations carried out, the Mela B3 users noticed a 98% reduction in dark spots within the first week of use and 100% in quantity and size after two weeks, even on the darkest stains.

Mela B3 is ideal for correcting different types of spots on all skin tones. It can be used, for example, to treat melasma, a commonly acquired skin disorder that presents as bilateral facial pigmentation, with brown spots. It is also effective for solar lentigo, known as age spot, solar or hepatic, a hyperpigmented, raised or flat spot that develops on parts of the skin that have been exposed to the sun for prolonged periods. It is also used in treatments against post-inflammatory hyperpigmentation (PIH), a common skin disorder that occurs after inflammation or injury to the skin.

This product is ideal for correcting spots on different skin types and tones.

“Skin spots can arise due to various factors such as sun exposure, genetic predisposition, use of medications, hormonal changes or simply aging. The skin acts as a protective barrier that isolates the organism from the environment, and pigment production is a defense mechanism against attacks such as solar radiation, pollution and stress,” explained the dermatologist, Andrea Rey (MN 139.411).

For more than a century, L’Oréal Groupe has been a leader in advanced beauty sciences, with 35 years of research dedicated to skin pigmentation. Melasyl was first presented at the World Congress of Dermatology 2023 in Singaporealong with the first global epidemiological study on pigment disorders, and recently at the American Academy of Dermatology annual meeting in San Diego on March 8-12, 2024.

 
For Latest Updates Follow us on Google News
 

-